Please login to the form below

Not currently logged in


This page shows the latest phenotyping news and features for those working in and with pharma, biotech and healthcare.

Takeda explores the potential of ‘digital biomarkers’

Takeda explores the potential of ‘digital biomarkers’

The firm is collaborating with Mindstrong Health, whose digital phenotyping platform continuously measures brain function from passively collected smartphone data.

Latest news

  • G8 sets 2025 target for effective dementia treatment G8 sets 2025 target for effective dementia treatment

    GlaxoSmithKline is the first industrial partner in the project. Meanwhile, the MRC is also considering mass phenotyping of people with early-stage neurodegenerative diseases to complement its genotyping efforts aimed at

  • UK phenome lab opens for business UK phenome lab opens for business

    scale metabolic phenotyping centre able to analyse up to 100, 000 blood and urine samples every year. ... will provide phenotyping services to researchers both in the UK and around the world.

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Raising Awareness: It’s World COPD Day today!

    Novel treatment approaches for COPD. Phenotyping and personalised medicine. The latest GOLD guidelines do not fully reflect the heterogeneous nature of the disease, but instead represent a progress in the personalised

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Weber Shandwick

At Weber Shandwick, engagement has always been the cornerstone of health communications.We make health matter. Health is a basic human...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...